These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM. Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [Abstract] [Full Text] [Related]
4. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Ohike N, Kim GE, Tajiri T, Krasinskas A, Basturk O, Coban I, Bandyopadhyay S, Morohoshi T, Goodman M, Kooby DA, Sarmiento JM, Adsay NV. Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962 [Abstract] [Full Text] [Related]
6. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP. Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064 [Abstract] [Full Text] [Related]
7. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator. Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V. Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002 [Abstract] [Full Text] [Related]
8. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins. Perysinakis I, Minaidou E, Mantas D, Sotiropoulos GC, Leontara V, Tsipras H, Zografos GN, Margaris I, Kouraklis G. Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085 [Abstract] [Full Text] [Related]
9. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels. Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, Revetta F, Washington MK, Vnencak-Jones C, Shi C. Mod Pathol; 2014 May; 27(5):665-74. PubMed ID: 24186143 [Abstract] [Full Text] [Related]
10. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Gonzalez RS, Bagci P, Basturk O, Reid MD, Balci S, Knight JH, Kong SY, Memis B, Jang KT, Ohike N, Tajiri T, Bandyopadhyay S, Krasinskas AM, Kim GE, Cheng JD, Adsay NV. Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329 [Abstract] [Full Text] [Related]
11. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance]. Liu FF, Shen DH, Wang HL, Ma YT, Yuan F, Liu J, Chen L, Song QJ, Zhang YY. Zhonghua Bing Li Xue Za Zhi; 2019 Feb 08; 48(2):92-97. PubMed ID: 30695858 [Abstract] [Full Text] [Related]
13. Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging. Chung YE, Kim MJ, Park MS, Choi JY, Kim H, Kim SK, Lee M, Kim HJ, Choi JS, Song SY, Kim KW. Radiology; 2010 Nov 08; 257(2):384-93. PubMed ID: 20829529 [Abstract] [Full Text] [Related]
14. Intra-ampullary Papillary Tubular Neoplasm (IAPN): Clinicopathologic Analysis of 72 Cases Highlights the Distinctive Characteristics of a Poorly Recognized Entity. Tarcan ZC, Esmer R, Akar KE, Bagci P, Bozkurtlar E, Saka B, Armutlu A, Sahin Ozkan H, Ozcan K, Taskin OC, Kapran Y, Aydin Mericoz C, Balci S, Yilmaz S, Cengiz D, Gurses B, Alper E, Tellioglu G, Bozkurt E, Bilge O, Cheng JD, Basturk O, Adsay NV. Am J Surg Pathol; 2024 Sep 01; 48(9):1093-1107. PubMed ID: 38938087 [Abstract] [Full Text] [Related]
15. Adenocarcinoma of the minor duodenal papilla and its precursor lesions: a clinical and pathologic study. Shia J, Agaram NP, Olgac S, Cobanov B, Adsay V, Klimstra DS. Am J Surg Pathol; 2014 Apr 01; 38(4):526-33. PubMed ID: 24625417 [Abstract] [Full Text] [Related]
16. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J. J Gastrointest Surg; 2010 Apr 01; 14(4):719-28. PubMed ID: 20107918 [Abstract] [Full Text] [Related]
17. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes. Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M, Tsutani Y. Oncol Rep; 2006 May 01; 15(5):1157-61. PubMed ID: 16596179 [Abstract] [Full Text] [Related]
18. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Adsay V, Ohike N, Tajiri T, Kim GE, Krasinskas A, Balci S, Bagci P, Basturk O, Bandyopadhyay S, Jang KT, Kooby DA, Maithel SK, Sarmiento J, Staley CA, Gonzalez RS, Kong SY, Goodman M. Am J Surg Pathol; 2012 Nov 01; 36(11):1592-608. PubMed ID: 23026934 [Abstract] [Full Text] [Related]
19. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater. Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS. Am J Surg Pathol; 2014 Oct 01; 38(10):1371-9. PubMed ID: 24832159 [Abstract] [Full Text] [Related]
20. Mucins differently expressed in various ampullary adenocarcinomas. Wang T, Liang YM, Hu P, Cheng YF. Diagn Pathol; 2011 Oct 25; 6():102. PubMed ID: 22027009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]